Ensign Peak Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Hold |
|
|||||
|
2025
Q1 | $1.31M | Buy |
|
|||||
|
2024
Q4 | $1.23M | Buy |
|
|||||
|
2024
Q3 | $1.62M | Hold |
|
|||||
|
2024
Q2 | $1.2M | Hold |
|
|||||
|
2024
Q1 | $1.36M | Sell |
|
|||||
|
2023
Q4 | $1.46M | Hold |
|
|||||
|
2023
Q3 | $1.09M | Hold |
|
|||||
|
2023
Q2 | $1.41M | Buy |
|
|||||
|
2023
Q1 | $1.21M | Hold |
|
|||||
|
2022
Q4 | $1.4M | Sell |
|
|||||
|
2022
Q3 | $4.72M | Buy |
|
|||||
|
2022
Q2 | $5.09M | Buy |
|
|||||
|
2022
Q1 | $1.07M | Hold |
|
|||||
|
2021
Q4 | $1.24M | Buy |
|